Related Experiment Videos
Cefuroxime in bacterial meningitis
Abstract:
In order to find an alternative antimicrobial treatment for childhood bacterial meningitis 30 infants and children with meningitis, due to Haemophilus influenzae (n = 13), Neisseria meningitis (n = 9), Streptococcus pneumoniae (n = 5), or meningitis of unknown aetiology (n = 3), were treated with cefuroxime, 200 mg/kg a day, as the only antibiotic. Prompt clinical and bacteriological responses were noted and every patient was cured. Cefuroxime concentrations in cerebrospinal fluid ranged from 1.1 to 18.8 (mean 7.0) mg/l at the beginning and from 0.5 to 4.1 (mean 1.6) mg/l at the end of treatment. Three infants developed symptomatic sterile subdural effusions which were managed by repeated subdural aspirations while still on antibiotics. Cefuroxime concentrations in the subdural fluid ranged from 17.4 to 32.4 mg/l. At follow-up 2 patients had moderate unilateral hearing loss and one had mild ataxia. We conclude that cefuroxime is effective and safe for the treatment of childhood bacterial meningitis caused by any of these common organisms.
Insights
Cefuroxime effectively treated bacterial meningitis in children, showing prompt clinical and bacteriological responses. This antibiotic proved safe and curative for common meningitis pathogens in infants and children.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Pharmacology
- Microbiology
Background:
- Bacterial meningitis remains a significant cause of childhood morbidity and mortality.
- Identifying effective and safe antimicrobial agents is crucial for pediatric infectious disease management.
Purpose of the Study:
- To evaluate the efficacy and safety of cefuroxime as a sole antibiotic treatment for childhood bacterial meningitis.
- To determine cefuroxime's pharmacokinetic profile in cerebrospinal fluid (CSF) and subdural fluid.
Main Methods:
- A cohort of 30 infants and children with bacterial meningitis received cefuroxime (200 mg/kg/day).
- Clinical and bacteriological outcomes were monitored.
- Cerebrospinal fluid and subdural fluid cefuroxime concentrations were measured.
Main Results:
- All 30 patients achieved clinical and bacteriological cure.
- Cefuroxime demonstrated adequate penetration into the CSF and subdural fluid.
- Three patients developed sterile subdural effusions, successfully managed with aspiration.
Conclusions:
- Cefuroxime is an effective and safe antimicrobial agent for treating childhood bacterial meningitis caused by common pathogens.
- The study supports cefuroxime as a viable treatment option in pediatric meningitis.